证券代码：002408 证券简称：齐翔腾达 淄博齐翔腾达化工股份有限公司投资者关系活动记录表 编号：20251126 投资者关系活动 类别 ☑ 特定对象调研 □ 分析师会议 □ 媒体采访 □ 业绩说明会 □ 新闻发布会 □ 路演活动 □ 现场参观 □ 电话会议 □ 其他 参与单位名称及 人员姓名 长城财富资管 王卫华 寒武纪投资 刘备 田园 方正证券 杨宇禄 东方财富证券 梅宇鑫 时间 2025 年 11 月 26 日 地点 公司会议室 上市公司接待人 员姓名 董事会秘书 姜能成 证券事务代表 车俊侠 投资者关系活动 主要内容介绍 一、公司董事会秘书姜能成先生就公司生产经营情况进行 介绍。 二、调研的主要问题： 1、公司 MMA 产品当前的市场行情，下一步是否有继续向下 游延伸的规划？ 回复：公司当前 MMA 的价格约为 9500 元/吨，处于行业主流 价格区间。装置产能稳定，能够满足现有市场需求。公司正积极 推进产业链延伸布局，计划依托 MMA 产品的优势，向下游高端材 料领域拓展，重点延伸至 PMMA（聚甲基丙烯酸甲酯）等高性能 树脂材料领域，以提升产品附加值。目前，公司正与相关科研院 所开展 PMMA ...

氯碱产业链、LPG 与橡胶——无化不谈 20251121 摘要 PVC 新增产能显著，但房地产需求疲软和出口不确定性导致基本面偏弱。 截至 10 月中旬，外购电石的 PVC 利润进一步亏损，10 月上旬山东外购 电石的 PVC 利润跌至负 300 元以下，并进一步扩大至负 350~-400 元 区间。 短期内，PVC 开工率预计维持高位，但印度反倾销政策是出口核心变量。 印度前期集中补库，10 月份新增订单趋于一般且采购意愿下降，预计四 季度出口量将较三季度小幅回落。11 月 12 日印度宣布撤销包括 PVC 在 内的 14 类化工品 BS 认证要求，这一变化将减少 BS 认证对出口造成的 波动。 PVC 库存水平明显高于往年同期，截至 11 月中旬最新库存为 50.59 万 吨，同比增加约 25%。高库存主要由于新增产能投放、检修减少及需求 不足所致。在没有大规模减产或显著改善出口之前，库存去化难度仍然 较大。 烧碱方面，2025 年计划投产新产能，供应端压力依然较大。自 11 月以 来烧碱价格持续小幅回落至 2,450 元左右，ECU 利润回落至 200~300 元区间，好于 8~9 月份水平，使得烧碱开 ...

Core Viewpoint - Qixiang Tengda's stock price has shown a slight decline this year, with a recent drop of 2.17% on November 20, 2023, reflecting ongoing challenges in its financial performance and market position [1][2]. Financial Performance - For the period from January to September 2025, Qixiang Tengda reported a revenue of 18.212 billion yuan, a year-on-year decrease of 0.77%, and a net profit attributable to shareholders of -146 million yuan, representing a significant decline of 174.19% [2]. - Cumulatively, since its A-share listing, Qixiang Tengda has distributed a total of 2.643 billion yuan in dividends, with 908 million yuan distributed over the past three years [3]. Stock Market Activity - As of November 20, 2023, Qixiang Tengda's stock was trading at 4.97 yuan per share, with a total market capitalization of 14.129 billion yuan. The stock has experienced a year-to-date decline of 0.60% and a 5-day decline of 2.36% [1]. - The company had a total of 56,700 shareholders as of October 20, 2025, with an average of 48,502 circulating shares per shareholder, which decreased by 0.21% compared to the previous period [2]. Shareholder Composition - As of September 30, 2025, the top ten circulating shareholders included Hong Kong Central Clearing Limited, which increased its holdings by 8.6957 million shares to 26.4683 million shares. New entrants among the top shareholders included Penghua Zhongzheng Fine Chemical Industry Theme ETF and Guangfa Advantage Growth Stock A [3].

本周（2025/11/10-2025/11/14）化工板块整体涨跌幅表现排名第9位，涨跌幅为2.61%，走势处于市场整 体中上游。上证综指涨跌幅为-0.18%，创业板指涨跌幅为-3.01%，申万化工板块跑赢上证综指2.79个百 分点，跑赢创业板指5.62个百分点。 华安证券近日发布基础化工行业周报：本周（2025/11/10-2025/11/14）化工板块整体涨跌幅表现排名第9 位，涨跌幅为2.61%，走势处于市场整体中上游。上证综指涨跌幅为-0.18%，创业板指涨跌幅 为-3.01%，申万化工板块跑赢上证综指2.79个百分点，跑赢创业板指5.62个百分点。 以下为研究报告摘要： 主要观点： 行业周观点 2025年化工行业景气度将延续分化趋势，推荐关注合成生物学、农药、层析介质、代糖、维生素、轻烃 化工、COC聚合物、MDI等行业: （1）合成生物学奇点时刻到来。能源结构调整大背景下，化石基材料或在局部面临颠覆性冲击，低耗 能的产品或产业有望获得更长成长窗口。对于传统化工企业而言，未来的竞争在于能耗和碳税的成本， 优秀的传统化工企业会利用绿色能源代替方案、一体化和规模化优势来降低能耗成本，亦或新增产能转 移至 ...

Core Viewpoint - The announcement from Qixiang Tengda highlights that anti-involution policies will help curb low-level redundant construction in the chemical industry, promote the elimination of backward production capacity, and facilitate the industry's transition from price competition to technological, efficiency, and green development [1] Industry Summary - The anti-involution policies are expected to enhance industry concentration, benefiting leading enterprises through improved market order [1] - The company has minimal old production capacity over 20 years and has completed equipment upgrades, indicating a low risk of short-term impact from policies [1] - The company’s production facilities for phthalic anhydride, MMA, and propylene oxide utilize advanced and environmentally friendly technologies, maintaining technical competitiveness for an extended period [1] Company Strategy - The company plans to leverage its advanced production capacity to optimize product structure and increase the proportion of high value-added products [1] - The company will closely monitor policy directions and market changes, actively adjusting its business strategies, enhancing cost control and operational efficiency [1] - Continuous optimization of existing resources will be pursued to solidify the company's leading position in niche markets, aiming for higher quality development during the industry's recovery phase [1]

Group 1: Company Performance and Market Conditions - The company's performance in the first three quarters of 2025 was relatively weak, with significant losses in Q3 due to declining prices of major chemical products and supply-demand mismatches. However, there are signs of recovery expected in Q4 driven by inventory demand and improved market conditions [1][2]. - In Q3 2025, the company reported a capital expenditure reduction among most listed companies, indicating a trend towards more controlled capacity expansion [1][2]. - The company exported 545,000 tons of products in the first three quarters of 2025, generating $350 million in export revenue, reflecting stable growth in export business [4]. Group 2: Policy Impact and Industry Trends - The anti-involution policy is expected to curb low-level repetitive construction in the chemical industry, promoting the elimination of outdated capacity and shifting the industry focus towards technology, efficiency, and green development [2]. - The company has minimal old capacity over 20 years and has completed equipment upgrades, positioning it to benefit from improved market order due to the policy [2]. Group 3: Strategic Initiatives and Future Plans - The company is exploring new application scenarios for its core products to enhance value and market space, such as expanding the use of acetone in semiconductor cleaning [3]. - The company is actively seeking opportunities for industrial collaboration to optimize resource allocation and enhance overall competitiveness [2][3]. - There are plans for strategic acquisitions and integrations in the current market downturn, as the valuation of target companies with mature technologies is low, which could strengthen the company's position in high-value product lines [3].

Q&A 纯碱、顺酐——大宗商品热点解读 20251114 摘要 顺酐市场供需失衡加剧，2024 年起产能大幅扩张，至 2025 年总产能 达 357 万吨，较 2021 年增长 187.9%，但下游需求增速滞后，导致工 厂开工率普遍偏低，预计未来几年供需矛盾依旧严峻，市场价格或将持 续承压。 顺酐价格持续走弱，2025 年多数时间低于 2024 年水平，与原材料正 丁烷价差收窄，成本支撑减弱。多数工厂面临严重亏损，利润长期徘徊 在负值区间，仅在特殊时期出现短暂盈利，行业整体经营状况堪忧。 国内纯碱产能快速扩张，2020 年至 2025 年增加超过 1,000 万吨，总 产能达 4,450 万吨，主要集中在河南、内蒙古、江苏等地，天然碱项目 成为扩张主力，推动因素包括政府支持、市场需求增长和技术改进。 纯碱生产成本因工艺方法而异，天然碱具有显著成本优势，合成氨法和 联氨法成本波动较大。环保政策趋严，高耗能、高成本的小型装置或将 逐步退出，未来新增产能预计以天然碱为主。 纯碱行业开工率在 2025 年出现波动，夏季检修和下游需求变化是主要 影响因素。重质纯碱需求增加，轻重质比例发生变化。各地区间价格存 在差异，华 ...

融券方面，齐翔腾达11月11日融券偿还3700.00股，融券卖出5600.00股，按当日收盘价计算，卖出金额 2.82万元；融券余量43.11万股，融券余额217.27万元，超过近一年50%分位水平，处于较高位。 11月11日，齐翔腾达涨0.80%，成交额8558.00万元。两融数据显示，当日齐翔腾达获融资买入额1168.27 万元，融资偿还877.27万元，融资净买入291.00万元。截至11月11日，齐翔腾达融资融券余额合计4.06 亿元。 融资方面，齐翔腾达当日融资买入1168.27万元。当前融资余额4.04亿元，占流通市值的2.82%，融资余 额低于近一年30%分位水平，处于低位。 资料显示，淄博齐翔腾达化工股份有限公司位于山东省淄博市临淄区杨坡路206号，成立日期2002年1月 4日，上市日期2010年5月18日，公司主营业务涉及甲乙酮、顺酐、丙烯、甲基丙烯酸甲酯、叔丁醇、异 辛烷、MTBE、石油和化工各类催化剂等产品以及能源、化工产品贸易等供应链管理业务。主营业务收 入构成为：顺酐化工类42.93%，国外贸易35.28%，化工其他类10.72%，甲乙酮类8.96%，其他(补 充)2.12%。 截至 ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [8]. Core Views - The company reported a revenue of 18.212 billion yuan for the first three quarters of 2025, a year-on-year decrease of 0.77%. The net profit attributable to the parent company was -146 million yuan, down 174.19% year-on-year. The net profit excluding non-recurring items was -144 million yuan, a decline of 182.20% year-on-year [2][6]. - In Q3 2025, the company achieved a revenue of 6.004 billion yuan, an increase of 6.75% year-on-year but a decrease of 8.89% quarter-on-quarter. The net profit attributable to the parent company was -169 million yuan, turning to a loss both year-on-year and quarter-on-quarter [2][6]. - The company is positioned as a leader in the C4 industrial chain, with significant competitive advantages. It focuses on deep processing of raw material C4, forming four product lines, including but not limited to methyl ethyl ketone, maleic anhydride, MMA, and nitrile latex, with a market share of approximately 70% in China [13]. - The company is expanding into the C3 industrial chain, with projects including a propane dehydrogenation project and an epoxy propane project. However, the supply-demand imbalance in the epoxy propane market poses challenges to profitability [13]. - The projected net profits for the company from 2025 to 2027 are estimated to be 60 million yuan, 490 million yuan, and 910 million yuan, respectively, with corresponding price-to-earnings ratios of 246.1x, 28.7x, and 15.4x [13]. Summary by Sections Financial Performance - For the first three quarters of 2025, the company reported a total revenue of 18.212 billion yuan, a decrease of 0.77% year-on-year. The net profit attributable to the parent company was -146 million yuan, a decline of 174.19% year-on-year, and the net profit excluding non-recurring items was -144 million yuan, down 182.20% year-on-year [2][6]. - In Q3 2025, the revenue was 6.004 billion yuan, up 6.75% year-on-year but down 8.89% quarter-on-quarter. The net profit attributable to the parent company was -169 million yuan, indicating a loss both year-on-year and quarter-on-quarter [2][6]. Market Position and Strategy - The company is a leader in the C4 industrial chain, focusing on the deep processing of raw material C4, with a strong market presence in products like methyl ethyl ketone and maleic anhydride. The company benefits from its location in Shandong, which has abundant refining resources [13]. - The company is also developing its C3 industrial chain, with several projects underway. However, the supply-demand dynamics in the epoxy propane market are challenging, affecting profitability [13]. Future Outlook - The company anticipates net profits of 60 million yuan, 490 million yuan, and 910 million yuan for the years 2025, 2026, and 2027, respectively, with corresponding price-to-earnings ratios indicating potential growth [13].

Core Viewpoint - Qixiang Tengda's stock price has shown fluctuations, with a recent increase of 2.07% and a total market value of 14.044 billion yuan, despite a year-to-date decline of 1.20% [1] Financial Performance - For the period from January to September 2025, Qixiang Tengda reported a revenue of 18.212 billion yuan, a year-on-year decrease of 0.77%, and a net profit attributable to shareholders of -146 million yuan, a significant decline of 174.19% [2] - Cumulative cash dividends since the company's A-share listing amount to 2.643 billion yuan, with 908 million yuan distributed over the past three years [3] Shareholder Structure - As of September 30, 2025, the number of shareholders increased to 56,600, with an average of 48,602 circulating shares per person, a decrease of 0.28% [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 8.6957 million shares, and new entrants such as Penghua Zhongzheng Fine Chemical Industry Theme ETF and Guangfa Advantage Growth Stock A [3]